Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
| (Q1)Dec 31, 2025 | (FY)Sep 30, 2025 | (Q4)Sep 30, 2025 | (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 119.14%1.3M | -576.79%-1.93M | -258.69%-8.78M | 213.33%5.52M | 735.97K | 328.70%594.29K | 123.42%405.46K | 799.19%5.53M | -362.42%-4.87M | 0 |
| Net income from continuing operations | 154.90%372.39K | -24.47%-3.64M | 64.19%-1.87M | -111.28%-294.4K | ---794.13K | -125.48%-678.32K | 34.08%-2.93M | -1,100.91%-5.23M | 547.06%2.61M | --0 |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | 64.99%-87.7K | --0 | 187.17%13.83K | --0 |
| Depreciation and amortization | 708.16%74.56K | 589.47%275.11K | 2,567.11%252.68K | -80.52%3.92K | --9.27K | -10.32%9.23K | -2.95%39.9K | -7.83%9.47K | 97.77%20.14K | --0 |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | -19,148.78%-1.36M | -3,958.35%-668.05K | -119.06%-36.06K | -498.24%-623.47K | ---1.43K | 95.47%-7.09K | -107.20%-16.46K | -105.88%-16.46K | --156.56K | --0 |
| Remuneration paid in stock | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---61.85K | ---- |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non cashItems | -42.57%261.83K | -62.79%745.06K | -92.82%450.73K | 83.88%-707.31K | --545.74K | 292.72%455.9K | 478.00%2M | 1,980.38%6.28M | -17,325.06%-4.39M | --0 |
| Change In working capital | 140.34%1.96M | -2.65%1.36M | -186.33%-7.57M | 194.51%7.14M | --976.51K | 371.74%814.57K | 5,371.09%1.39M | 646.29%8.77M | -1,050.77%-7.55M | --0 |
| -Change in receivables | -99.38%-21.04K | -43.45%-47.15K | -75.22%-16.52K | -5,681.39%-34.49K | --14.41K | 56.14%-10.55K | -303.23%-32.87K | -154.00%-9.43K | -94.39%618 | --0 |
| -Change in prepaid assets | -13.04%-65.65K | -58.42%-840.69K | -187.52%-7.27M | 202.76%9.16M | ---2.67M | -179.56%-58.07K | -875.13%-530.66K | 727.57%8.31M | -17,405.16%-8.91M | --0 |
| -Change in payables and accrued expense | 131.48%2.04M | 14.69%2.24M | -159.97%-281.83K | -245.98%-1.99M | --3.63M | 613.77%883.2K | 2,970.84%1.96M | 269.28%469.93K | 1,087.62%1.36M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 119.14%1.3M | -576.79%-1.93M | -189.53%-8.78M | 160.35%5.52M | --735.97K | 328.70%594.29K | 123.42%405.46K | 1,980.44%9.81M | -591.22%-9.14M | --0 |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -268.00%-6.17M | 37.78%-9.98M | 127.37%2.81M | -73.04%-9.57M | -1.55M | -630.76%-1.68M | -351.71%-16.03M | -6,506.38%-10.27M | -102.13%-5.53M | 0 |
| Capital expenditure reported | ---- | 0.00%-412.59K | ---- | ---- | ---- | ---- | ---412.59K | ---- | ---- | ---- |
| Net PPE purchase and sale | -287.59%-5.97M | 38.78%-9.56M | 131.26%3.15M | -77.40%-9.64M | ---1.53M | -1,208.59%-1.54M | -391.99%-15.62M | -1,832.95%-10.07M | -147.63%-5.43M | --0 |
| Net other investing changes | -47.98%-202.87K | ---- | ---- | ---- | ---- | -22.65%-137.09K | -10.18%-412.59K | 82.30%-205.44K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -268.00%-6.17M | 37.78%-9.98M | 127.37%2.81M | -73.04%-9.57M | ---1.55M | -630.76%-1.68M | -351.71%-16.03M | -510.94%-10.27M | -357.41%-5.53M | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,411.11%9.16M | 388.56%17.44M | -66.61%241.17K | 239.03%14.19M | 2.41M | -95.35%606.31K | -47.20%3.57M | 390.81%722.38K | -267.31%-10.2M | 0 |
| Net issuance payments of debt | -525.88%-1.06M | 964.72%15.91M | -108.64%-131.49K | 208.15%13.92M | --1.87M | -98.07%247.82K | -76.05%1.49M | 4,635.32%1.52M | -313.53%-12.88M | --0 |
| Net common stock issuance | 556.46%813.73K | -98.44%42.13K | -524.47%-456.88K | -95.26%123.03K | --252.02K | --123.96K | --2.71M | 2,377.97%107.63K | --2.6M | --0 |
| Proceeds from stock option exercised by employees | 343.41%512.16K | 1,426.32%882.98K | --362K | --0 | --405.47K | --115.51K | --57.85K | --0 | --57.85K | --0 |
| Net other financing activities | 7,370.55%8.89M | -94.91%605.29K | 131.67%467.56K | ---- | ---- | -41.37%119.02K | 2,181.03%11.9M | -1,332.66%-1.48M | 19,098.33%13.17M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,411.11%9.16M | 7.92%17.44M | 56.87%241.19K | 380.10%14.19M | --2.41M | -95.35%606.31K | 139.02%16.16M | 4.47%153.75K | -51.55%2.95M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 258.65%7.95M | 33.27%2.22M | 437.52%13.46M | -75.75%3.45M | -89.09%1.55M | 33.27%2.22M | 1,140.20%1.66M | 16.09%2.5M | 12,466.38%14.21M | 12,251.46%14.21M |
| Current changes in cash | 1,002.64%4.3M | 940.76%5.53M | -1,711.57%-5.73M | 186.53%10.14M | --1.6M | -103.79%-475.83K | -64.10%531.28K | 40.34%-316.07K | -673.88%-11.71M | --0 |
| Effect of exchange rate changes | -409.73%-969.89K | 825.29%205.29K | 651.01%214.48K | -2,446.62%-119.14K | --300.23K | -1,561.93%-190.27K | -55.46%22.19K | -20.70%28.56K | 55.78%5.08K | --0 |
| End cash Position | 627.06%11.28M | 258.65%7.95M | 258.65%7.95M | 437.52%13.46M | -75.75%3.45M | -89.09%1.55M | 33.27%2.22M | 33.27%2.22M | 16.09%2.5M | 12,466.38%14.21M |
| Free cash from | -393.53%-4.66M | 23.79%-11.91M | -792.81%-6.04M | 72.52%-3.97M | -746.70%-946.39K | -150.35%-945.04K | -215.96%-15.63M | 35.05%-676.97K | -335.92%-14.46M | -311.08%-111.77K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.